Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
Ouyang Z, Guo X, Chen X, Liu B, Zhang Q, Yin Z, Zhai Z, Qu X, Liu X, Peng D, Shen Y, Liu T, Zhang Q.
Ouyang Z, et al. Among authors: chen x.
Oncotarget. 2017 Dec 4;9(2):1868-1884. doi: 10.18632/oncotarget.22930. eCollection 2018 Jan 5.
Oncotarget. 2017.
PMID: 29416737
Free PMC article.